--United Bancorp Lifts Quarterly Dividend 6% to $0.1775 per Share, Payable Sept. 20 to Shareholders of Record on Sept. 10-February 2024-www.financetom.com

--United Bancorp Lifts Quarterly Dividend 6% to $0.1775 per Share, Payable Sept. 20 to Shareholders of Record on Sept. 10

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

--United Bancorp Lifts Quarterly Dividend 6% to $0.1775 per Share, Payable Sept. 20 to Shareholders of Record on Sept. 10

Aug 22, 2024 10:13 PM

11:24 AM EDT, 08/22/2024 (MT Newswires) --

Price: 11.73, Change: +0.32, Percent Change: +2.85

Previous page： Google agrees $36 million fine for anti-competitive deals with Australia telcos Next page： Sunrun (RUN) Stock Is Rising: What's Going On?

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

Sunrun (RUN) Stock Is Rising: What's Going On?

Jun 18, 2025

Shares of Sunrun Inc ( RUN ) cratered by more than 40% Tuesday, leading a widespread downturn in the solar energy sector. Following Tuesday’s dramatic sell-off, shares are staging a modest recovery in early Wednesday trading. What To Know: Tuesday’s sharp sell-off followed the unveiling of a new tax bill by the U.S. Senate Finance Committee that proposes a significant...

Maia Biotechnology Signs Clinical Supply Deal With Roche; Shares Rise

Jun 18, 2025

12:08 PM EDT, 06/18/2025 (MT Newswires) -- Maia Biotechnology ( MAIA ) shares were up Wednesday after the company said it has signed a clinical master supply agreement with Roche. The deal will support future studies testing Maia's cancer drug candidate, ateganosine, alongside Roche's checkpoint inhibitor, atezolizumab, the company said. The combination will be studied as a potential treatment for...

--EU Antitrust Authorities Planning Probe Into Mars' $35.9 Billion Bid for Kellanova, Reuters Reports

Jun 18, 2025

12:07 PM EDT, 06/18/2025 (MT Newswires) -- Price: 79.28, Change: -0.95, Percent Change: -1.18 ...